tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
PremiumRatingsBioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
1M ago
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
Premium
Company Announcements
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
1M ago
BioCryst reports preliminary Q4 ORLADEYO revenue $151M
Premium
The Fly
BioCryst reports preliminary Q4 ORLADEYO revenue $151M
1M ago
BioCryst price target raised to $32 from $30 at H.C. Wainwright
PremiumThe FlyBioCryst price target raised to $32 from $30 at H.C. Wainwright
2M ago
BioCryst’s Avoralstat Study: A New Hope for Diabetic Macular Edema?
Premium
Company Announcements
BioCryst’s Avoralstat Study: A New Hope for Diabetic Macular Edema?
2M ago
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
2M ago
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe FlyBioCryst reports inducement grants under Nasdaq listing rule
3M ago
BioCryst Announces Early Termination for Astria Merger
Premium
Company Announcements
BioCryst Announces Early Termination for Astria Merger
3M ago
BioCryst receives early termination of HSR waiting period for Astria acquisition
Premium
The Fly
BioCryst receives early termination of HSR waiting period for Astria acquisition
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100